Valepotriate
Valepotriate can be isolated from Valeriana jatamansi Jones, has anti-epileptic and anti-cancer activities[1][2].
Product Specifications
CAS Number
18296-44-1
Product Name Alternative
Valtrate
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Apoptosis
Type
Natural Products
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/valepotriate.html
Purity
99.93
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(CC(C)C)O[C@@H]1[C@]2(CO2)[C@]([C@@H]3OC(CC(C)C)=O)([H])C(C(COC(C)=O)=CO3)=C1
Molecular Formula
C22H30O8
Molecular Weight
422.47
Precautions
H315, H319, H335
References & Citations
[1]Yan YY, et al. A novel derivative of valepotriate inhibits the PI3K/AKT pathway and causes Noxa-dependent apoptosis in human pancreatic cancer cells. Acta Pharmacol Sin. 2020 Feb 11.|[2]Wu A, et al. Anti-epileptic Effects of Valepotriate Isolated from Valeriana jatamansi Jones and Its Possible Mechanisms. Pharmacogn Mag. 2017 Jul-Sep;13 (51) :512-516.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040257-500 1x 500 µL
Cytokeratin, HMW (AE-3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040276-100 1x 100 µL
TAG-72 / CA72.4 (B72.3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400040-100 1x 100 µL
CD35 / CR1 (E11), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740753-500 1x 500 µL
Cytokeratin 19 (A53-B/A2.26 + BA17), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740049-500 1x 500 µL
CD31 / PECAM-1 (C31.3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details